Key takeaways
- Maintenance-phase treatment may remain medically necessary when ongoing skilled care is needed to sustain treatment gains, reduce the risk of another depressive episode, or prevent deterioration or hospitalization.Â
- Denials more frequently happen in the maintenance phase because documentation doesn't explain why treatment is still necessary; every note needs diagnosis, functional status, intervention, and progress tied together explicitly.
- A stable PHQ-9 trend should prompt reassessment—not automatically discharge or continued treatment. Consider whether the client can safely reduce or end treatment. If ongoing sessions remain necessary because stopping or stepping down would create a meaningful risk of relapse, recurrence, or functional deterioration, document that risk and the continued need for skilled care, and update the treatment plan at least every 90 days.
- When clinically appropriate, use a documented, gradual step-down plan and monitor the client’s response. If treatment continues at the current frequency, clearly document why stepping down would create clinical risk.Â
Let’s say a client has been stable for eight months. Their PHQ-9 scores have held in the low single digits for three consecutive sessions. They're functioning well at work, their relationships have improved, and by most measures, they’re doing pretty darn well..
Does that mean therapy is no longer medically necessary? Maybe, and that possibility deserves genuine consideration. Stability should prompt a thoughtful reassessment of whether the client is ready to reduce session frequency or end treatment. For some clients, the answer will be yes. For others, a history of recurrent or severe depressive episodes, residual symptoms, previous deterioration after treatment ended, ongoing stressors, or limited supports may indicate that stepping down would create a meaningful risk of relapse, recurrence, or functional decline.
In those cases, “the client remains stable” is not enough to justify ongoing care. The record needs to explain what is helping the client maintain that stability, why skilled psychotherapy is still required, what could reasonably happen if treatment were reduced or withdrawn, and how the need for continued treatment and current frequency will be reassessed.
This article is about how to document this phase of treatment: what the maintenance phase actually is, how documentation needs to shift once a client gets there, and the specific language that demonstrates ongoing medical necessity without overstating risk or understating progress.
What Is the Maintenance Phase of Depression Treatment?
Depression treatment is commonly understood as occurring in three phases, each with a distinct clinical purpose:
This framework is described in the American College of Physicians’ clinical guideline on major depressive disorder treatment. The distinction between relapse and recurrence is important to recognize.Â
- Relapse refers to the return of symptoms before the current depressive episode has fully resolved.Â
- Recurrence refers to a new episode after the person has recovered.Â
Maintenance treatment recognizes that recovery from one episode does not necessarily eliminate the risk of another.
Importantly, the timeframes indicated in the table above are approximations, not fixed thresholds for moving from one phase to another. A client’s treatment phase should be determined by their symptom course, functioning, residual symptoms, treatment response, episode history, and risk of future episodes—not simply by how many weeks or months they have been in treatment.
Maintenance treatment can include medication management, psychotherapy, self-management strategies, or a combination of approaches. Being in the maintenance phase does not, by itself, establish medical necessity for ongoing psychotherapy at the same frequency. Clinicians must periodically assess whether skilled treatment remains necessary, whether sessions can be reduced or ended, and what clinical risks would be associated with stepping down or discontinuing care.
Assessing the Risk of Relapse or Recurrence
Deciding whether to continue maintenance-phase psychotherapy requires more than noting that depression is recurrent or that symptoms could return. The clinician should identify the client’s specific risk factors and consider how likely the client is to lose current gains if treatment is reduced or discontinued.
The National Institute for Health and Care Excellence identifies several factors associated with greater risk of future depressive symptoms or episodes:
- Recurrent episodes, particularly when episodes have occurred frequently or within the past two years
- Incomplete response to treatment or persistent residual symptoms
- A history of severe depression or substantial functional impairment
- Co-occurring mental or physical health conditions
- Coping patterns such as avoidance or rumination
- Ongoing personal, social, or environmental stressors that contributed to the depression, including relationship difficulties, isolation, unemployment, or financial hardship NICE
The assessment should also consider the client’s individual treatment history. Previous symptom worsening after treatment ended, difficulty maintaining gains at a lower frequency, limited support outside therapy, or identifiable stressors on the horizon may influence the decision to continue care. Protective factors—including effective coping skills, supportive relationships, stable functioning, and the ability to recognize and respond to early warning signs—should be considered as well.
No single risk factor automatically establishes medical necessity. A history of recurrent depression may support continued care, but the documentation should connect that history to the client’s present clinical needs. It should explain which risks remain active, how ongoing skilled treatment addresses them, why the current frequency is appropriate, and when the need for continued treatment will be reassessed.
For example:
The client remains at elevated risk of recurrence due to three prior depressive episodes, residual sleep disruption, ongoing caregiving stress, and a history of symptom escalation after previous treatment discontinuation. Continued monthly psychotherapy focuses on monitoring early warning signs, strengthening behavioral and interpersonal relapse-prevention strategies, and addressing current stressors associated with prior episodes. Treatment frequency will be reassessed in 90 days based on symptom measures, functioning, and the client’s ability to maintain gains between sessions.
Why Maintenance-Phase Notes Are Uniquely Vulnerable to Denial
Maintenance-phase notes can be especially vulnerable to denial because the client’s stability may make ongoing treatment appear unnecessary.Â
Acute-phase documentation are typically easier to account for medical necessity because of the presence of more acute symptoms and impairment in functioning. These also make it easier to develop treatment goal that aim to provide relief.
Maintenance-phase documentation doesn't have that same narrative arc, and that's exactly the problem. When a client is stable, it is all too easy to write a note that simply confirms stability. without explaining why continued treatment is still necessary. This reads to a utilization reviewer as "this person no longer needs therapy." The clinical reasoning that justifies ongoing care has to be stated explicitly, every time, because reviewers evaluate only what's written in that note, not what's understood.
What Specific Language Demonstrates Medical Necessity in Maintenance-Phase Notes?
Every progress note, regardless of phase, should connect four elements: diagnosis, current functional status, the specific intervention used, and the client's response relative to treatment plan goals. This line that runs through each note connecting these elements is often called the "golden thread." Each note should visibly connect back to the diagnosis and treatment plan, not stand alone as an unconnected summary of what was discussed.
In the maintenance phase specifically, this means a few adjustments to how you write:
Name the mechanism, not just the activity. "Discussed coping skills" tells a reviewer nothing about why the session was clinically necessary. "Reviewed relapse-prevention plan and reinforced use of behavioral activation strategies following an increase in work stress" shows clinical reasoning connected to a specific risk factor.
State what continued treatment is accomplishing, even when nothing changed. A stable presentation is itself a documented outcome. For example: "Client's PHQ-9 score has remained in the minimal range for three consecutive sessions, consistent with continued treatment response. Monthly sessions continue to reinforce coping strategies and monitor for early signs of symptom recurrence given client's history of two prior major depressive episodes."
Reference individual recurrence risk factors, not generic risk. "Client remains at elevated risk for recurrence" is a weak statement on its own. "Client has a history of three major depressive episodes, a known risk factor for recurrence; current maintenance-phase treatment is directed at relapse prevention" is specific and clinically grounded.
Avoid repeating identical language across sessions. Auditors specifically look for cloned or near-identical notes as a sign that documentation isn't individualized to the session. Even in a stable maintenance phase, each note should reflect something, whether that be a stressor, a skill reinforced, a subtle shift in presentation, specific to that encounter.
Documenting Functional Status and Relapse Risk
Functional impairment doesn't disappear as a documentation requirement just because a client has improved. Arguably, it becomes an even more important part of each progress note.
Useful elements to document thoughtfully:
- Current functional baseline. What does the client's daily functioning actually look like now compared to when they were symptomatic? Be inclusive of any settings from their workplace, relationships, and other routines.Â
- Specific recurrence risk factors. Episode history (number and severity of prior episodes), residual symptoms, ongoing or anticipated psychosocial stressors, and age at first onset are all recognized predictors of recurrence.
- Early warning signs being monitored. If a client has a known early-warning pattern (sleep disruption, withdrawal, irritability), document that you're actively watching for it, as this demonstrates clinical vigilance, not just scheduled check-ins.
- What would happen without continued treatment. This doesn't need to be dramatic. A simple, honest statement gives a reviewer the clinical rationale they're looking for. For example, “Discontinuation of treatment at this time would increase risk of symptom recurrence given client's episode history."
One clinically important point: residual symptoms can be a strong predictor of relapse. If your client has any lingering symptoms, even mild ones, documenting them specifically (rather than noting "client doing well" and leaving it at that) directly supports the case for continued care.
Updating Treatment Plans Without Implying a Lack of Progress
For many therapists, the instinct is to leave an existing treatment plan untouched because "it's working" or nothing seems to have changed. However, static, outdated treatment plans are themselves a documentation risk, since reviewers expect periodic updates that reflect the client's actual current status.
Treatment plan updates in the maintenance phase should document consolidation, not stagnation.
Practical ways to do this:
- Update goal language from acquisition to maintenance. A goal like "client will learn and practice two coping strategies for depressive symptoms" can be revised to "client will maintain consistent use of established coping strategies (playing an instrument, socializing outside of the home, going on walks)  “client will identify and verbalize early warning signs of symptom recurrence to therapist in the weeks that they happen." These goals reflect the client’s current functioning without suggesting treatment has stalled.
- Document a step-down rationale explicitly, even if discharge isn't imminent. Reviewers tend to look more favorably on a stated plan than open-ended continuation. Language like "Session frequency will be reassessed for potential reduction as stability is sustained across the next two quarterly reviews" shows the treatment has direction and possibly an end, which reassures reviewers that care is being actively managed rather than continued by default.
- Reassess, and re-document, every 90 days, even if nothing about the plan changes substantively. Payers generally expect treatment plan reviews on this cadence.
If you're not sure your current treatment plan template includes the necessary elements, Blueprint's guide to creating effective treatment plans walks through how to structure goals, interventions, and review timelines so the document itself makes the medical necessity case, not just the notes underneath it.
How Do You Prevent Common Reasons Claims From Getting Denied in the Maintenance Phase?
Recurring failure or denial patterns include:
- Vague or generic clinical language that doesn't connect to a specific intervention or functional status ("provided supportive therapy," "discussed feelings")
- Notes that read identically across multiple sessions, suggesting the documentation wasn't individualized
- Missing or inconsistent time documentation. Clock-in/clock-out times that don't match the billed CPT code
- No documented connection between the session and the treatment plan's active goals
- Treatment plans that haven't been updated to reflect the client's current clinical status
If a claim is denied, it's worth knowing that appeals are not a lost cause: industry analysis has found that well-documented appeals from mental health consumers overturn claim denials somewhere between 39% and 59% of the time. The gap between a denial and an approval is frequently just a matter of the documentation stating explicitly what was clinically true all along.
The Role of the PHQ-9 and Other Standardized Measures
Standardized tools like the PHQ-9 matter more in the maintenance phase than therapists sometimes assume: they turn potentially subjective opinion into an objective, reviewable data point.
A few practical notes on using the PHQ-9 and other outcome measures in this phase:
- A low, stable score is evidence the current plan is working. It’s not evidence that treatment can stop. Frame it that way explicitly in your notes: "PHQ-9 of 4, consistent with sustained remission under current maintenance-phase treatment plan," rather than just recording the number.
- Trend data is more persuasive than a single score. A reviewer can dismiss one low score as a snapshot; three or four consecutive low scores, documented over time, demonstrate a maintained treatment effect.
- Administer consistently, even when sessions feel routine. Gaps in measurement make it harder to demonstrate a continuous trend when a review happens.
Three Situations That Require Specific Documentation Adjustments
When Treatment Moves from Acute or Continuation Phase to Maintenance
The core shift in documentation emphasis: acute and continuation phase notes justify intensity: why this frequency, why this intervention, why right now? Maintenance-phase notes justify continuation:Â why stopping now would increase risk? If you've been writing acute-style justifications (focused on symptom severity) well past the point where a client has stabilized, your documentation and your client's actual clinical picture may no longer match.
When Care Involves a Collaborative or Integrated Care Model
In collaborative care arrangements, documentation needs to reflect the team structure, not just the clinical content. This generally means recording care coordination activities (case reviews, communication with the prescribing or supervising provider), not only direct client contact, and showing that standardized measures are being used to drive treatment adjustments rather than passively recorded. Because billing and documentation requirements for collaborative care arrangements are specific and can vary by payer and setting, verify the current requirements for your particular model and payer before relying on this structure for reimbursement.
When a Client Has Had Multiple Prior Authorizations Approved and Is Facing Step-Down Pressure
The more times a client's care has been reauthorized, the more scrutiny each subsequent request may receive, and the easier it is to fall into writing increasingly repetitive notes across review periods. Make sure each new authorization period documents something that has genuinely evolved, a changed risk factor, a new stressor, a refined relapse-prevention focus, rather than restating the same justification used in the prior period. If session frequency is being questioned, a documented, gradual step-down plan is generally more persuasive to a reviewer than an open-ended argument for maintaining the current frequency indefinitely.
The Bottom Line
Medical necessity in the maintenance phase isn't about convincing a reviewer that your client is sicker than they are. It's about making the clinical reasoning for continued services obvious.
That reasoning almost always comes down to the same thing: this client has a history that makes recurrence a real risk, and continued treatment is actively managing that risk. Say that, specifically, tied to this client's history and this session's content, and the documentation is as strong as it can be.
Frequently Asked Questions
What do I do if I've been writing continuation or acute phase notes for a client who's already stabilized?
Update your documentation to match the client's current status before the next review. Continuing acute-style, symptom-severity language after a client has stabilized creates a mismatch between the notes and the actual clinical picture itself. Shift to maintenance-phase framing: name the specific recurrence risk being managed rather than describing symptoms that are no longer present.
Can a low PHQ-9 score hurt a client's chances of continued therapy authorization?
Not if it's framed correctly. A sustained low score only works against authorization when the note does not give the score context. Document the trend as evidence the current plan is working, write about elevated scores that occurred recently, if applicable, and pair these comments with specific recurrence risk factors (episode history, residual symptoms) that explain what the score is actually protecting against.
Does writing a step-down plan in a progress note mean you have to reduce sessions on that timeline?
No. A step-down plan shows clinical direction, not a binding commitment. If the client's presentation changes before the planned review point, the plan can be revised and the change documented.Â
How does documentation change for depression treatment in a collaborative care model?
The same core principles apply, golden thread documentation, specific recurrence risk, PHQ-9 trends, but collaborative care also requires documenting care coordination activity, such as case reviews and communication with the prescribing provider. Billing and documentation requirements vary by payer and setting, so confirm current requirements before relying on this structure for reimbursement.
Does having multiple prior authorizations approved make the next renewal easier?
Not necessarily. It may be the opposite is true where later authorization requests tend to get more scrutiny, not less, depending on the circumstances and payer. Repetitive, near-identical justifications across review periods are a common audit flag. Each new request should document something that has genuinely evolved since the last one.
Is it worth appealing a denied mental health insurance claim?‍
Usually, yes. Well-documented appeals from behavioral health consumers overturn mental health claim denials somewhere between 39% and 59% of the time. A denial often reflects a documentation gap rather than an actual absence of medical necessity.

